Phosphodiesterase 6D, cGMP-specific rod delta subunit (PDE6D)

Phosphodiesterase 6D (PDE6D) is a protein found in vertebrates, most abundantly in retinal rod photoreceptors where it forms the delta subunit of the rod-specific cGMP phosphodiesterase complex (PDE6)[1][3][9]. The catalytic PDE6 holoenzyme is essential for the visual transduction cascade, linking light activation to changes in cyclic nucleotide–gated ion channels. PDE6D’s primary documented function is as a solubilization and transport factor for certain membrane-associated, prenylated proteins, assisting their trafficking within photoreceptor and other cell types[3][6][7]. While the detailed catalytic or regulatory role of PDE6D itself in cGMP metabolism remains under investigation, it is necessary for the assembly and localization of the PDE6 enzyme complex in rod cells[1][3][9]. Genetic variants and dysfunctions in PDE6D are linked to specific retinal diseases and ciliopathies, including Joubert syndrome subtype 22 (JBTS22), manifesting in vision abnormalities and broader developmental issues[6][8][9]. No clinical drugs target PDE6D directly; research efforts focus on modulators of phototransduction proteins, especially for retinal degenerative disease[2].

Other names

Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit deltaGMP-PDE deltaProtein p17PDEDJBTS22

No confirmed mechanism for drug targeting; allosteric regulation of PDE6 complex may involve PDE6D, but primary mechanisms in literature involve catalytic subunits and G protein activation[2][9]